Abstract With the Green Deal the EU aims to achieve a circular economy, restore biodiversity
and reduce environmental pollution. As a part of the Green Deal a 'one-substance one …

Faster, cheaper, sensitive, and mechanisms‐based animal alternatives are needed to
address the safety assessment needs of the growing number of nanomaterials (NM) and …

The Stockholm Convention is key to addressing the global threats of persistent organic
pollutants (POPs) to humanity and the environment. It has been successful in identifying new …

Interest in behavioural ecotoxicology is growing, partly due to technological and
computational advances in recording behaviours but also because of improvements of …

Data generated by the rapidly evolving human biomonitoring (HBM) programmes are
providing invaluable opportunities to support and advance regulatory risk assessment and …

Identification of endocrine disruptors (EDs) is a highly prioritized issue in the EU. However,
scientific criteria to identify EDs have so far only been implemented for biocidal and plant …

Background Pharmaceuticals treat and prevent diseases but can pose a risk to organisms,
predominantly in aquatic environments. The use of pharmaceuticals is predicted to increase …

Our aim was to evaluate policies and procedures for management of conflict of interest (CoI)
and other sources of bias, implemented in Occupational Exposure Limit (OEL) expert …

Regulatory authorities rely on hazard and risk assessments performed under REACH for
identifying chemicals of concern and to take action. Therefore, these assessments must be …

As scientists, we are tasked with letting evidence guide our conclusions. In the world of
pesticides this takes on added importance as the data can influence ecological and human …